Literature DB >> 12082919

Overview of causes of COPD. New understanding of pathogenesis and mechanisms can guide future therapy.

Stephen I Rennard1.   

Abstract

Recent studies have greatly expanded the understanding of pathogenetic mechanisms underlying COPD. Cigarette smoking is the most important cause. Activation of inflammatory mechanisms in the lung leads to tissue damage by a variety of mechanisms. Active proteases and oxidants are believed to play crucial roles. In response to this injury, repair mechanisms are activated. Unfortunately, these repair mechanisms also may be adversely affected by cigarette smoking. Insufficient repair of alveolar structures in response to injury likely leads to emphysema. Repair with scarring likely leads to airflow limitation in chronic bronchitis. Moreover, mediators that drive these processes have systemic effects that contribute to the syndromes characteristic of COPD. Understanding these mechanisms has created novel therapeutic approaches to the management of this disorder.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12082919     DOI: 10.3810/pgm.2002.06.1223

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  4 in total

1.  The effect of preexisting respiratory co-morbidities on burn outcomes.

Authors:  Laquanda T Knowlin; Lindsay B Stanford; Bruce A Cairns; Anthony G Charles
Journal:  Burns       Date:  2016-10-27       Impact factor: 2.744

2.  Effect of simvastatin on MMPs and TIMPs in cigarette smoke-induced rat COPD model.

Authors:  Jiawei Sun; Jie Bao; Yanan Shi; Bin Zhang; Lindong Yuan; Junhong Li; Lihai Zhang; Mo Sun; Ling Zhang; Wuzhuang Sun
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-02-22

3.  The impact of the involvement of a healthcare professional on the usage of an eHealth platform: a retrospective observational COPD study.

Authors:  Cathelijne M van Zelst; Marise J Kasteleyn; Esther M J van Noort; Maureen P M H Rutten-van Molken; Gert-Jan Braunstahl; Niels H Chavannes; Johannes C C M In 't Veen
Journal:  Respir Res       Date:  2021-03-21

Review 4.  Triple Therapy in COPD: Can We Welcome the Reduction in Cardiovascular Risk and Mortality?

Authors:  Paolo Solidoro; Carlo Albera; Fulvia Ribolla; Michela Bellocchia; Luisa Brussino; Filippo Patrucco
Journal:  Front Med (Lausanne)       Date:  2022-03-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.